While the ability of Mfsd2a to suppress transcytosis is a universal principle of BBB maintenance, its paramount importance in ischemic stroke is highlighted by the acute and explosive nature of caveolae‐mediated transcytosis activation in this context. The gene discussed is MFSD2A; the disease is ischemic stroke.